Clariden Investment Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
7
- Exits
-
4

Clariden Investment General Information
Description
Clariden Investment was a venture capital firm that preferred to invest in the biotechnology sector.
Contact Information
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
- Switzerland
Clariden Investment Investments (7)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Santhera Pharmaceuticals | 01-Oct-2006 | Early Stage VC | 0000 | Biotechnology | Generating Revenue/Not Profitable | |
00000000 000000000 | 01-Jan-2005 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
00000 000000000000 | 17-Aug-2004 | 00000 00000 | 0000 | Drug Delivery | Profitable | |
00000 000000000000 | 25-May-2004 | 00000 00000 | 0000 | Biotechnology | Out of Business | |
00000000 | 30-Mar-2004 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
Altus Pharmaceuticals | 26-Dec-2001 | Later Stage VC | 000.00 | Biotechnology | Out of Business | |
CyDex Pharmaceuticals | 11-Oct-2000 | Early Stage VC | 0000 | Drug Delivery | Profitable |
Clariden Investment Exits (4)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
CyDex Pharmaceuticals | 26-Jan-2011 | Merger/Acquisition | 000.00 |
00000000 000000000 | 03-Nov-2006 | 000 | 000.00 |
Altus Pharmaceuticals | 26-Jan-2006 | IPO | 00000 |
Salmedix | 14-Jun-2005 | Merger/Acquisition | 00000 |